miRDDCR: a miRNA-based method to comprehensively infer drug-disease causal relationships

Revealing the cause-and-effect mechanism behind drug-disease relationships remains a challenging task. Recent studies suggested that drugs can target microRNAs (miRNAs) and alter their expression levels. In the meanwhile, the inappropriate expression of miRNAs will lead to various diseases. Therefore, targeting specific miRNAs by small-molecule drugs to modulate their activities provides a promising approach to human disease treatment. However, few studies attempt to discover drug-disease causal relationships through the molecular level of miRNAs. Here, we developed a miRNA-based inference method miRDDCR to comprehensively predict drug-disease causal relationships. We first constructed a three-layer drug-miRNA-disease heterogeneous network by combining similarity measurements, existing drug-miRNA associations and miRNA-disease associations. Then, we extended the algorithm of Random Walk to the three-layer heterogeneous network and ranked the potential indications for drugs. Leave-one-out cross-validations and case studies demonstrated that our method miRDDCR can achieve excellent prediction power. Compared with related methods, our causality discovery-based algorithm showed superior prediction ability and highlighted the molecular basis miRNAs, which can be used to assist in the experimental design for drug development and disease treatment. Finally, comprehensively inferred drug-disease causal relationships were released for further studies.

[1]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[2]  E. Wang,et al.  Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. , 2014, Seminars in cancer biology.

[3]  Jianxin Wang,et al.  A Framework for Integrating Multiple Biological Networks to Predict MicroRNA-Disease Associations , 2017, IEEE Transactions on NanoBioscience.

[4]  R. Sharan,et al.  PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.

[5]  Xing Chen,et al.  Drug-target interaction prediction by random walk on the heterogeneous network. , 2012, Molecular bioSystems.

[6]  Xing Chen,et al.  Semi-supervised learning for potential human microRNA-disease associations inference , 2014, Scientific Reports.

[7]  Xia Li,et al.  SM2miR: a database of the experimentally validated small molecules' effects on microRNA expression , 2013, Bioinform..

[8]  Jian-Fu Chen,et al.  The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation , 2006, Nature Genetics.

[9]  Noam Shomron,et al.  MicroRNAs and pharmacogenomics. , 2010, Pharmacogenomics.

[10]  Maoqiang Xie,et al.  Prioritizing Disease Genes by Bi-Random Walk , 2012, PAKDD.

[11]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2013 , 2012, Nucleic Acids Res..

[12]  Xiangxiang Zeng,et al.  Inferring MicroRNA-Disease Associations by Random Walk on a Heterogeneous Network with Multiple Data Sources , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[13]  D. Bartel MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[14]  Yi Pan,et al.  Predicting MicroRNA-Disease Associations Based on Improved MicroRNA and Disease Similarities , 2018, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[15]  Hailin Chen,et al.  Prediction of Associations between OMIM Diseases and MicroRNAs by Random Walk on OMIM Disease Similarity Network , 2013, TheScientificWorldJournal.

[16]  Zuping Zhang,et al.  Network-Based Inference Methods for Drug Repositioning , 2015, Comput. Math. Methods Medicine.

[17]  Xing Chen,et al.  IRWRLDA: improved random walk with restart for lncRNA-disease association prediction , 2016, Oncotarget.

[18]  Zejun Li,et al.  Identifying human microRNA-disease associations by a new diffusion-based method , 2015, J. Bioinform. Comput. Biol..

[19]  Jing Wang,et al.  Identifying novel associations between small molecules and miRNAs based on integrated molecular networks , 2015, Bioinform..

[20]  Xing Chen,et al.  PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction , 2017, PLoS Comput. Biol..

[21]  V Giesbrecht,et al.  From dream to reality. , 1987, The Kansas nurse.

[22]  Qionghai Dai,et al.  WBSMDA: Within and Between Score for MiRNA-Disease Association prediction , 2016, Scientific Reports.

[23]  N. Rajewsky,et al.  A pancreatic islet-specific microRNA regulates insulin secretion , 2004, Nature.

[24]  Peng Wang,et al.  A novel method to quantify gene set functional association based on gene ontology , 2012, Journal of The Royal Society Interface.

[25]  Xing Chen,et al.  RKNNMDA: Ranking-based KNN for MiRNA-Disease Association prediction , 2017, RNA biology.

[26]  Hailin Chen,et al.  A miRNA-Driven Inference Model to Construct Potential Drug-Disease Associations for Drug Repositioning , 2015, BioMed research international.

[27]  Q. Cui,et al.  An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.

[28]  Yong Zhao,et al.  Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis , 2005, Nature.

[29]  Mingzhi Liao,et al.  Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses , 2012, Scientific Reports.

[30]  G. Calin,et al.  Targeting MicroRNAs With Small Molecules: From Dream to Reality , 2010, Clinical pharmacology and therapeutics.

[31]  et al.,et al.  Computational analysis and predictive modeling of small molecule modulators of microRNA , 2012, Journal of Cheminformatics.

[32]  Feng Xu,et al.  Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information , 2015, Nucleic Acids Res..

[33]  Karin M. Verspoor,et al.  Duplicates, redundancies and inconsistencies in the primary nucleotide databases: a descriptive study , 2016, bioRxiv.

[34]  Hailin Chen,et al.  Similarity-based methods for potential human microRNA-disease association prediction , 2013, BMC Medical Genomics.

[35]  Xing Chen,et al.  DRMDA: deep representations‐based miRNA–disease association prediction , 2017, Journal of cellular and molecular medicine.

[36]  Lorena Rossi,et al.  Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. , 2007, Pharmacological research.

[37]  Q. Cui,et al.  Principles of microRNA regulation of a human cellular signaling network , 2006, Molecular systems biology.

[38]  Q. Zou,et al.  Prediction of MicroRNA-Disease Associations Based on Social Network Analysis Methods , 2015, BioMed research international.

[39]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[40]  Xing Chen miREFRWR: a novel disease-related microRNA-environmental factor interactions prediction method. , 2016, Molecular bioSystems.

[41]  Xing Chen,et al.  NRDTD: a database for clinically or experimentally supported non-coding RNAs and drug targets associations , 2017, Database J. Biol. Databases Curation.

[42]  David S. Wishart,et al.  DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..

[43]  Cheng Liang,et al.  Collective Prediction of Disease-Associated miRNAs Based on Transduction Learning , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[44]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[45]  Yoshihiro Yamanishi,et al.  Systematic Drug Repositioning for a Wide Range of Diseases with Integrative Analyses of Phenotypic and Molecular Data , 2015, J. Chem. Inf. Model..

[46]  Xing Chen,et al.  RWRMDA: predicting novel human microRNA-disease associations. , 2012, Molecular bioSystems.

[47]  Yan Zhang,et al.  Constructing and characterizing a bioactive small molecule and microRNA association network for Alzheimer's disease , 2014, Journal of The Royal Society Interface.

[48]  Yi Pan,et al.  Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm , 2016, Bioinform..

[49]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[50]  V. Ambros The functions of animal microRNAs , 2004, Nature.

[51]  Xing Chen,et al.  HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction , 2016, Oncotarget.

[52]  J. Bajorath,et al.  Polypharmacology: challenges and opportunities in drug discovery. , 2014, Journal of medicinal chemistry.

[53]  F. Slack,et al.  The let-7 microRNA reduces tumor growth in mouse models of lung cancer , 2008, Cell cycle.

[54]  Xiaojun Chen,et al.  Large-scale prediction of microRNA-disease associations by combinatorial prioritization algorithm , 2017, Scientific Reports.

[55]  M. Kanehisa,et al.  Development of a chemical structure comparison method for integrated analysis of chemical and genomic information in the metabolic pathways. , 2003, Journal of the American Chemical Society.